Thank you to our Foundational and Sustaining members
ROCHESTER, Minn., December 11, 2019 – Vyriad, Inc., a clinical-stage biotechnology company developing oncolytic virus therapies to treat a wide range of cancers, today announced the appointment of experienced life sciences investors Edwin M. Kania, Jr. and Nathan L. Stacy to the Company’s board of directors. Mr. Kania was named Chairman of the Board. Mr. […]
Starkey Livio AI: The 100 Best Inventions of 2019 In Silicon Valley, startup cofounder battles VC over the future of health insurance Cancer-killing virus designer Vyriad raises $24.4 million 3M, Medtronic lead Minnesota companies on Management Top 250 list Mayo Clinic expands out of U.S. with Abu Dhabi hospital ExceleraRx, a network for expensive specialty […]
Stryker announces definitive agreement to acquire Wright Medical for $5.4 Billion Regeneron and Vyriad Announce Strategic Agreement for Discovery and Development of New Oncolytic Virus Treatments for Cancer Maple Grove-based Pursuit Vascular sold for $75 million to California firm Digi International spends $140 million to buy New Jersey IT company In $660 Million Deal, Takeda […]
Phase 2 trial will evaluate combination of PD-1 inhibitor Libtayo® (cemiplimab-rwlc) and oncolytic virus Voyager-V1; preclinical research collaboration will explore new oncolytic virus treatments Vyriad to receive upfront payment and equity investment from Regeneron TARRYTOWN, N.Y., and ROCHESTER, Minn. (November 6, 2019) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Vyriad, Inc. today announced a research collaboration and option […]
FDA adds back some workers during partial government shutdown University of Minnesota tests ‘smart’ pills to give cancer patients a nudge Denmark picks Minnesota as its ‘bridge’ to U.S. med-tech A Pea-Sized Device Is Approved to Close Holes in Hearts of Tiny Infants Zoll Medical wins $400m DoD patient monitoring supply contract Ecolab Closes on […]
Rochester, MN (August 21, 2018) – After one year, since its official launch, the Southeast Minnesota Capital Fund LLC (Fund) has reached its $2,000,000 funding goal and closed its fifth investment in Rochester-based Ambient Clinical Analytics. “For our community, having an active new business fund is very important because we are helping attract and retain […]
Medical Alley companies had a strong start to 2018, buoyed by new investments in biotech. 45 companies raised $234 million in the first half of the year. In addition to positive investment flow, exits continued at a strong pace with multiple acquisitions and one initial public offering (IPO). These exits will recycle capital into the […]
Implantable Organ Developer Miromatrix Medical Raises $15.7M Minnesota health tech company accepted to world’s largest tech incubator, Station F in Paris Relievant Announces First Commercial Intracept Procedures Abbott Receives FDA Approval for Next-Generation MitraClip® Device To Treat People With Leaky Heart Valves Inspire Medical CEO on going public, ramping up growth and ringing the […]
Ecolab Ranks Eighth on 2018 Best Corporate Citizens List Why Medtronic’s CEO Wants to Bring Values-Based Healthcare to Everyone Boston Scientific’s drug-coated balloon succeeds in femoropopliteal segment at one year U of M Honored as One the World’s Best at Spinning Off Companies from Research Coloplast Announces the Launch of Biatain® Silicone with 3DFit Technology™ […]
Sansoro Health Raises $5.2 Million to Drive Integration of Digital Health Applications with Electronic Medical Records Rochester Startup Vyriad Expanding, Signs Lease for Ex-IBM Building DeviceTalks, Medical Alley Partner to Create a World-Class, Medtech Experience Only at DeviceTalks Minnesota Partnerships Make a More Affordable Campus Mayo Plans ‘Training and Command Center’ Creating IT Futures, Minneapolis Urban […]